Lasa Supergenerics Ltd Financials
Company Logo

Lasa Supergenerics Ltd Financial Statement

Lasa Supergenerics Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Sep 2024
Revenue41.34
Operating Expense38.60
Net Profit-3.23
Net Profit Margin-7.81
Earning Per Share-0.64
EBIDTA0.82
Effective Tax RateTBA
Invest in Lasa Supergenerics Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions

Lasa Supergenerics Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual104.34
Operating Expenses Annual102.17
Operating Profit Annual-6.51
Interest Annual1.93
Depreciation10.67
Net Profit Annual-21.73
Tax Annual2.62

Lasa Supergenerics Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning0.80
Cash Flow from Operations2.14
Cash Flow from Investing-0.40
Cash Flow from Financing-1.93
Cash Flow at the End0.61

Lasa Supergenerics Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)2.22
PBIT Margin (%)-8
PBT Margin (%)-3.97
Net PROFIT Margin (%)-20.83
Return On Networth / Equity (%)TBA
Return On Networth /Employed (%)TBA
Return On Assets (%)-16.66
Total Debt / Equity (X)0.20
Asset Turnover Ratio (%)0.80

Lasa Supergenerics Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual109.76
Total Current Assets Annual37.89
Non Current Assets Annual112.98
Total Shareholders Funds Annual96.68
Total Assets Annual150.87

Lasa Supergenerics Ltd Earning Calls

No Data Availabe

Get Your FAQs Right

As of Nov 24, 2024, Lasa Supergenerics Ltd has a market capitalization of 110.07 Cr. Value Research classifies it as a Micro-Cap company.
Yes, Lasa Supergenerics Ltd is debt-free with a debt-to-equity ratio of 0.23.
In FY 2023 , Lasa Supergenerics Ltd recorded a total revenue of approximately 104.34 Cr marking a significant milestone in the company's financial performance.
Lasa Supergenerics Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately -0.2% and -0.1% annually, respectively..
Lasa Supergenerics Ltd's current PE ratio is -5.07.
Lasa Supergenerics Ltd's ROCE averaged -6.3% from the FY ending March 2022 to 2024, with a median of -7.1%. It peaked at 1.1% in March 2022, reflecting strong capital efficiency over the period..
Lasa Supergenerics Ltd's latest EBIT is Rs. -17.18 Cr, surpassing the average EBIT of Rs. -20.46 Cr over the 5 years..